课题基金 / 基金详情

Deciphering CD8 Dendritic Cell Development for the Improvement of Vaccine

Deciphering CD8 Dendritic Cell Development for the Improvement of Vaccine
破译 CD8 树突状细胞的开发以改进疫苗
批准号:
8785266
负责人:
Gary E. Grajales-Reyes
金额:
$2.92万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-08-01 至 2017-07-31

项目摘要

项目成果

Gary E. Grajales-Reyes的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):病毒感染和癌症是将从治疗性疫苗的改进中极大受益的疾病的例子。许多类型的这些疾病缺乏有效的治疗方法,使得开发这种疫苗成为优先事项,并且其详细说明是一个积极关注的领域,正如大量正在进行的临床试验所证明的那样。在疫苗开发和设计领域,主要取得的效果是 有效诱导体液免疫应答。然而,使用疫苗根除癌症和一些病原体将需要产生强大的细胞介导的免疫力,特别是CD 8 T细胞应答。目前,许多临床试验正在试图开发针对癌症的治疗性疫苗,并且感兴趣的共同过程是有效的抗原呈递给T细胞。自然,树突状细胞由于其优异的抗原呈递能力而成为疫苗设计的重要组成部分。特别是,CD 8常规树突状细胞(cDC)在这一过程中是最重要的,因为它们在交叉呈递中的关键作用和它们诱导细胞毒性T淋巴细胞效应子活性和记忆形成的有效能力。然而,尽管它们很重要,但这些细胞发育的机制尚不清楚,限制了我们选择性扩增CD 8 cDC群体的能力。然而,我们实验室最近的发现正在帮助我们理解这一过程。我们已经确定了小鼠品系之间的遗传背景差异,这将为我们提供鉴定CD 8 cDC定向祖细胞的必要工具。反过来,我们将能够对具有不同cDC发育潜力的祖细胞进行新的遗传分析和比较,以鉴定负责cDC两个分支发育的转录因子电路。之前我们的实验室显示Batf 3-/-小鼠缺乏CD 8 cDC。有趣的是,我们已经在Irf 8的启动子中鉴定了Batf 3依赖性Irf 8结合顺式元件,Irf 8是CD 8 cDC发育的关键转录因子。因此,我们的目的是测试CD 8 cDC的Irf 8表达维持是否依赖于这种顺式元件中的Irf 8-Batf 3复合物结合。这些发现将帮助我们理解cDC分化机制,从而可以开发CD 8 cDC的治疗性靶向扩增以改进疫苗设计。
英文摘要
DESCRIPTION (provided by applicant): Viral infections and cancer are examples of diseases that would greatly benefit from the improvement of therapeutic vaccines. The lack of effective treatments for many types of these diseases makes the development of such vaccines a priority and its elaboration is an area of active interest as evidenced by the great number of ongoing clinical trials. In the realm of vaccine development and design, the primary achieved effect is the potent induction of humoral immune responses. However, the use of vaccines to eradicate cancers and some pathogens will require the generation of robust cell-mediated immunity, particularly CD8 T-cell responses. Currently, numerous clinical trials are trying to develop therapeutic vaccinations against cancer and a common process of interest is the efficient antigen presentation to T cells. Naturally, dendritic cells have become an important component of vaccine design due to their excellent antigen presentation capacity. In particular, CD8 conventional dendritic cells (cDCs) are of the utmost importance in this process due to their critical role in cross-presentation and their potent ability to induce cytotoxic T-lymphocyte effector activity and memory formation. Nevertheless, in spite of their importance, the mechanism by which these cells develop is unknown, limiting our capacity to selectively expand the CD8 cDC population. However, recent findings in our laboratory are helping us to understand this process. We have identified genetic background differences amongst mouse strains that will provide us with the necessary tools for the identification of a CD8 cDC committed progenitor. In turn, we will be able to perform a novel genetic profiling and comparison of progenitors with different cDC developmental potential in order to identify the transcription factor circuitry responsible for the development of both branches of cDCs. Previously our laboratory showed that the Batf3-/- mice lack CD8 cDCs. Interestingly, we have identified a Batf3-dependent Irf8 binding cis-element in the promoter of Irf8, a critical transcription factor for the development of CD8 cDCs. Thus, we aim to test if the Irf8 expression maintenance of the CD8 cDCs depends on the Irf8-Batf3 complex binding in such cis-element. Such discoveries will help us understand the cDC differentiation mechanism so that therapeutic targeted expansion of CD8 cDCs can be developed for the improvement of vaccine design.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CAR-based approaches for the treatment of Alzheimer's Disease
  • 批准号:
    10706512
  • 项目类别:
  • 资助金额:
    $38.88万
  • 财政年份:
    2022
  • 负责人:
    Gary E. Grajales-Reyes
  • 依托单位:
CAR-based approaches for the treatment of Alzheimer's Disease
  • 批准号:
    10481511
  • 项目类别:
  • 资助金额:
    $39.29万
  • 财政年份:
    2022
  • 负责人:
    Gary E. Grajales-Reyes
  • 依托单位:
海外基金